Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends Constella in IBS-C

Sep. 25, 2012

EMA committee recommends approval of new apixaban indication

Sep. 25, 2012

Biovest provides update on planned MAA for NHL vaccine candidate

Sep. 21, 2012

RepliGen withdraws MAA for SecreFlo

Sep. 17, 2012

PM-01183 receives positive opinion for orphan drug status in E.U.

Sep. 10, 2012

ARIAD submits MAA to EMA

Aug. 31, 2012

EMA accepts MAA for Heplisav

Aug. 23, 2012

COMP issues opinion on Albireo's lead hepatology candidate

July 26, 2012

CHMP issues opinion on Dacogen

July 24, 2012

Celgene to request reexamination of CHMP opinion on Istodax MAA

July 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...